CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −18,770 | $64.36 | $1.2M | 2,723,526 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −37,445 | $65.63 | $2.5M | 2,686,081 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −18,316 | $66.55 | $1.2M | 2,667,765 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −14,945 | $67.57 | $1.0M | 2,652,820 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −6,011 | $68.50 | $412K | 2,646,809 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −3,482 | $69.59 | $242K | 2,643,327 |
| 2021-03-01 | Tessier-Lavigne Marc Director | Sale | −1,031 | $71.35 | $74K | 2,642,296 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −3,370 | $64.42 | $217K | 2,320,706 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −5,885 | $65.63 | $386K | 2,314,821 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −3,453 | $66.55 | $230K | 2,311,368 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −3,339 | $67.69 | $226K | 2,308,029 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −1,625 | $68.46 | $111K | 2,306,404 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −594 | $69.65 | $41K | 2,305,810 |
| 2021-03-01 | Watts Ryan J. President and CEO | Sale | −68 | $70.92 | $5K | 2,305,742 |
| 2021-02-16 | Krognes Steve E. CFO and Treasurer | Sale | −22,684 | $64.27 | $1.5M | 927,316 |
| 2021-02-16 | Krognes Steve E. CFO and Treasurer | Sale | −10,199 | $65.04 | $663K | 917,117 |
| 2021-02-16 | Krognes Steve E. CFO and Treasurer | Sale | −16,616 | $66.20 | $1.1M | 900,501 |
| 2021-02-16 | Krognes Steve E. CFO and Treasurer | Sale | −501 | $66.80 | $33K | 900,000 |
| 2021-02-12 | BRATTON DOUGLAS K 10% owner | Sale | −2,216,798 | $65.00 | $144.1M | 9,984,836 |
| 2021-02-11 | Ho Carole Chief Medical Officer | Sale | −2,756 | $70.17 | $193K | 172,633 |
Page 26 of 53 · 1,053 trades